Atovaquone Suspension
Product Images NDC 70166-488

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Atovaquone (NDC 70166-488). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lohxa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atovaquoneoscartonlabel (Atovaquonecup 20191219 204246)

Atovaquone is an oral suspension used strictly for oral consumption. It comes in a 750mg/SmL concentration and should be shaken gently before usage. The package contains 50 units of 5mL Atovaquone. Each 1mL contains 750mg of Atovaquone. The suspension should be stored at a temperature of 20-25°C and should not be frozen. Refer to the package insert for instructions on the recommended dosage and administration. The product is recommended for institutional use only and has been repackaged by 1Gnr::sul MAO180BU.SA [LOhxa]. Please visit www.lohxa.com for more information.*

FDA Label Image

Atovaquonestructure (Atovaquonestructure)

FDA Label Image

Address1 (Address1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.